Cargando…

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection

Detalles Bibliográficos
Autores principales:	Thelwall, Simon, Aiano, Felicity, Harman, Katie, Dabrera, Gavin, Ladhani, Shamez N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963774/ https://www.ncbi.nlm.nih.gov/pubmed/35364023 http://dx.doi.org/10.1016/S2352-4642(22)00096-7

Ejemplares similares

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

Increased risk of hospitalisation and death with the delta variant in the USA
por: Bast, Elizabeth, et al.
Publicado: (2021)

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021
por: Williams, Sarah V, et al.
Publicado: (2021)

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
por: Nyberg, Tommy, et al.
Publicado: (2022)

Variation in reported SARS-CoV-2 cases after testing policy changes
por: Halford, Florence, et al.
Publicado: (2022)

Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England”
por: Zsigmond, Borbàla, et al.
Publicado: (2022)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
por: Harris, Ross J., et al.
Publicado: (2021)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021
por: Aiano, Felicity, et al.
Publicado: (2022)

Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( )
por: Nyberg, Tommy, et al.
Publicado: (2022)

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England
por: Harman, Katie, et al.
Publicado: (2023)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
por: Wall, Emma C, et al.
Publicado: (2021)

Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study
por: Aiano, Felicity, et al.
Publicado: (2021)

Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021)

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
por: Rockett, Rebecca, et al.
Publicado: (2022)

Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan
por: Jang, Tyng-Yuan
Publicado: (2022)

Monkeypox and pregnancy: time for global surveillance and prevention strategies
por: Khalil, Asma, et al.
Publicado: (2022)

The need for better diagnostics to support diagnosis and surveillance in monkeypox endemic countries
por: Khalil, Asma, et al.
Publicado: (2023)

Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection
por: Twohig, Katherine A., et al.
Publicado: (2023)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants – Authors' reply
por: Nyberg, Tommy, et al.
Publicado: (2022)

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
por: Antonelli, Michela, et al.
Publicado: (2022)

Monkeypox in children: Update on the current outbreak and need for better reporting
por: Khalil, Asma, et al.
Publicado: (2022)

SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
por: Jeffery-Smith, Anna, et al.
Publicado: (2022)

Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England
por: Webster, H. H., et al.
Publicado: (2022)

COVID-19 screening of health-care workers in a London maternity hospital
por: Khalil, Asma, et al.
Publicado: (2021)

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
por: Sheikh, Aziz, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
por: Jordan, Stanley C., et al.
Publicado: (2021)

In-utero transmission of SARS CoV-2 infection during delta variant outbreak: first Australian experience
por: Duguid, Robert C., et al.
Publicado: (2022)

Predicting the risk of chest radiograph abnormality 12-weeks post hospitalisation with SARS CoV-2 PCR confirmed COVID-19
por: Wallis, Tim JM, et al.
Publicado: (2022)

Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison
por: Chin, Elizabeth T., et al.
Publicado: (2021)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Is spinal anaesthesia an aerosol-generating procedure? Transmission of SARS-CoV-2 from patient to anaesthetist
por: Plaat, Felicity, et al.
Publicado: (2020)

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England
por: Abdul Aziz, Nurin, et al.
Publicado: (2023)

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
por: Behrens, Georg MN, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
por: Jeffery-Smith, Anna, et al.
Publicado: (2021)

Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants
por: Leeman, D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fiu7ufhpecp3ik0jd2enrku7qg